Sol-Gel Technologies (SLGL) Common Equity (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Common Equity of $51.4 million for Q1 2026, up 154.84% year-over-year from $20.2 million in Q1 2025, and up 125.36% quarter-over-quarter from $22.8 million in Q4 2025.

Sol-Gel Technologies (SLGL) Common Equity (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Common Equity data on file, last reported at $51.4 million in Q1 2026.

  • Common Equity for Q1 2026 came in at $51.4 million, up 154.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.4 million (up 154.84% YoY), and the FY2025 annual result was $22.8 million, down 20.93% from the prior year.
  • Common Equity rose to $51.4 million in Q1 2026 per SLGL's latest filing, from $22.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $246.7 million in Q1 2023 and troughed at $20.2 million in Q1 2025.
  • A 5-year average of $71.6 million and a median of $38.6 million in 2023 frame the typical range for Common Equity.
  • The sharpest annual moves came in 2022 and 2024: Common Equity soared 495.17% in 2022, then tumbled 86.76% in 2024.
  • A 5-year view of Common Equity shows it stood at $42.2 million in 2022, then retreated by 8.45% to $38.6 million in 2023, then retreated by 25.34% to $28.8 million in 2024, then decreased by 20.93% to $22.8 million in 2025, then jumped by 125.36% to $51.4 million in 2026.
  • Business Quant data shows SLGL's Common Equity at $51.4 million in Q1 2026, $22.8 million in Q4 2025, and $26.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 35.63 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.42 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 13.21 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 51.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.41 Mn
Dec 31, 2025 22.81 Mn
Sep 30, 2025 26.03 Mn
Jun 30, 2025 31.88 Mn
Mar 31, 2025 20.17 Mn
Dec 31, 2024 28.85 Mn
Sep 30, 2024 34.71 Mn
Jun 30, 2024 34.90 Mn
Mar 31, 2024 32.65 Mn
Dec 31, 2023 38.64 Mn
Sep 30, 2023 43.13 Mn
Jun 30, 2023 48.30 Mn
Mar 31, 2023 246.68 Mn
Dec 31, 2022 42.21 Mn
Sep 30, 2022 47.47 Mn
Jun 30, 2022 233.59 Mn
Mar 31, 2022 233.22 Mn
Dec 31, 2021 55.59 Mn
Sep 30, 2021 41.44 Mn
Jun 30, 2021 39.25 Mn